1. Adam R, Karam V, Delvart V, OʼGrady J, Mirza D, Klempnauer J, et al. 2012; Evolution of indications and results of liver transplantation in Europe: a report from the European Liver Transplant Registry (ELTR). J Hepatol. 57:675–88. DOI:
10.1016/j.jhep.2012.04.015. PMID:
22609307.
Article
2. Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, et al. 2015; OPTN/SRTR 2013 annual data report: liver. Am J Transplant. 15 Suppl 2:1–28. DOI:
10.1111/ajt.13197. PMID:
25626341.
Article
3. Dopazo C, Bilbao I, Castells LL, Sapisochin G, Moreiras C, Campos-Varela I, et al. 2015; Analysis of adult 20-year survivors after liver transplantation. Hepatol Int. 9:461–70. DOI:
10.1007/s12072-014-9577-x. PMID:
25788182. PMCID:
PMC4473278.
Article
5. Firl DJ, Sasaki K, McVey J, Hupertz V, Radhakrishnan K, Fujiki M, et al. 2019; Improved survival following living donor liver transplantation for pediatric acute liver failure: analysis of 20 years of US National Registry data. Liver Transpl. 25:1241–50. DOI:
10.1002/lt.25499. PMID:
31119826.
6. Hwang S, Ha TY, Ahn CS, Moon DB, Kim KH, Song GW, et al. 2016; Standardized surgical techniques for adult living donor liver transplantation using a modified right lobe graft: a video presentation from bench to reperfusion. Korean J Hepatobiliary Pancreat Surg. 20:97–101. DOI:
10.14701/kjhbps.2016.20.3.97. PMID:
27621745. PMCID:
PMC5018955.
Article
7. Jung D, Hwang S, Ahn C, Moon D, Ha T, Song G, et al. 2021; Quilt unification venoplasty of the right hepatic veins enabling double inferior vena cava anastomosis in living donor liver transplantation using a right liver graft. Ann Liver Transplant. 1:86–94. DOI:
10.52604/alt.21.0004.
Article
8. Jung D, Hwang S, Song G. 2021; Selection criteria of living donor liver transplantation for hepatocellular carcinoma developed in Korean transplant centers. Ann Liver Transplant. 1:29–47. DOI:
10.52604/alt.21.0005.
Article
9. Min SI, Ahn C, Han DJ, Kim SI, Chung SY, Lee SK, et al. 2015; To achieve national self-sufficiency: recent progresses in deceased donation in Korea. Transplantation. 99:765–70. DOI:
10.1097/TP.0000000000000412. PMID:
25226175.
10. Hwang S, Lee SG, Lee YJ, Sung KB, Park KM, Kim KH, et al. 2006; Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl. 12:920–7. DOI:
10.1002/lt.20734. PMID:
16721780.
Article
11. Jung BH, Hwang S, Song GW, Jung DH, Ha TY, Park GC, et al. 2015; Updated status of deceased-donor liver graft allocation for high-urgency adult patients in a Korean high-volume liver transplantation center. Transplant Proc. 47:580–3. DOI:
10.1016/j.transproceed.2015.02.014. PMID:
25891690.
Article
12. Kim SH, Hwang S, Ahn C, Moon D, Ha T, Song G, et al. 2021; Absence of influence of the Korean MELD score-based liver allocation system on pretransplant MELD score in patients undergoing living donor liver transplantation. Ann Liver Transplant. 1:10–17. DOI:
10.52604/alt.21.0003.
Article
13. Hwang S, Lee SG, Ha TY, Ahn CS, Park KM, Kim KH, et al. 2004; Simplified standardized technique for living donor liver transplantation using left liver graft plus caudate lobe. Liver Transpl. 10:1398–405. DOI:
10.1002/lt.20241. PMID:
15497157.
Article
14. Lee SG, Song GW, Yoon YI. 2019; An exceptional series: 5000 living donor liver transplantations at Asan Medical Center, Seoul, Korea. Transplantation. 103:1739–41. DOI:
10.1097/TP.0000000000002708. PMID:
31461082.
Article
15. Kang SH, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, et al. 2020; Changes in the indications for living donor liver transplantation: single-institution experience of 3,145 cases over 10 years. Korean J Transplant. 34:47–54.
16. Hwang S, Lee SG, Ahn CS, Kim KH, Moon DB, Ha TY, et al. 2008; Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy. Liver Transpl. 14:770–8. DOI:
10.1002/lt.21440. PMID:
18508369.
Article
17. Hwang S, Ahn CS, Song GW, Kim KH, Moon DB, Oh HB, et al. 2011; Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on. Liver Transpl. 17:456–65. DOI:
10.1002/lt.22226. PMID:
21445929.
Article
18. Hwang S, Song GW, Chung YK, Ahn CS, Kim KH, Moon DB, et al. 2019; Determination of hepatitis B immunoglobulin infusion interval using pharmacokinetic half-life simulation for posttransplant hepatitis B prophylaxis. J Korean Med Sci. 34:e251. DOI:
10.3346/jkms.2019.34.e251. PMID:
31583871. PMCID:
PMC6776838.
Article
19. Park GC, Hwang S, Kim MS, Jung DH, Song GW, Lee KW, et al. 2020; Hepatitis B prophylaxis after liver transplantation in Korea: analysis of the KOTRY database. J Korean Med Sci. 35:e36. DOI:
10.3346/jkms.2020.35.e36. PMID:
32056398. PMCID:
PMC7025905.
Article
21. Hwang S, Namgoong JM. 2021; Tailored techniques of graft outflow vein reconstruction in pediatric liver transplantation at Asan Medical Center. Ann Liver Transplant. 1:58–70. DOI:
10.52604/alt.21.0006.
Article
22. Hwang S, Namgoong JM. 2021; Tailored standardization of portal vein reconstruction for pediatric liver transplantation at Asan Medical Center. Ann Liver Transplant. 1:71–78. DOI:
10.52604/alt.21.0007.
Article
24. Park HW, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, et al. 2012; De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry. Transplant Proc. 44:802–5. DOI:
10.1016/j.transproceed.2012.01.027. PMID:
22483500.
Article
25. Jung DH, Hwang S, Song GW, Ahn CS, Moon DB, Ha TY, et al. 2016; Survival benefit of early cancer detection through regular endoscopic screening for de novo gastric and colorectal cancers in Korean liver transplant recipients. Transplant Proc. 48:145–51. DOI:
10.1016/j.transproceed.2015.12.003. PMID:
26915860.
Article
26. Park GC, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, et al. 2020; Pretransplant hepatic malignancy increases risk of de novo malignancy after liver transplantation. J Korean Med Sci. 35:e69. DOI:
10.3346/jkms.2020.35.e69. PMID:
32193900. PMCID:
PMC7086089.
Article
27. Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, et al. 2018; A cross-sectional analysis of long-term immunosuppressive regimens after liver transplantation at Asan Medical Center: increased preference for mycophenolate mofetil. Ann Hepatobiliary Pancreat Surg. 22:19–26. DOI:
10.14701/ahbps.2018.22.1.19. PMID:
29536052. PMCID:
PMC5845607.
Article
28. Kang S, Hwang S, Ha T, Song G, Jung D, Ahn C, et al. 2019; Cross-sectional analysis of immunosuppressive regimens focused on everolimus after liver transplantation in a Korean high-volume transplantation center. Korean J Transplant. 33:98–105. DOI:
10.4285/jkstn.2019.33.4.98.
Article